Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Frontiers in Psychiatry
|
May 16, 2022
Efficacy of Transcranial Direct-Current Stimulation in Catatonia: A Review and Case Series
Alexandre Haroche, Nolwenn Giraud, Fabien Vinckier, et al.
Science Advances
|
December 15, 2021
Ultrasound modulation of macaque prefrontal cortex selectively alters credit assignment-related activity and behavior
Davide Folloni, Elsa Fouragnan, Marco K Wittmann, et al.
Physics in Medicine and Biology
|
May 22, 2024
Ultra-short time-echo based ray tracing for transcranial focused ultrasound aberration correction in human calvaria
Thomas J Manuel, Thomas Bancel, Thomas Tiennot, et al.
Psychiatry Research
|
January 31, 2025
Physical pain and suicide-related outcomes across the lifespan: systematic review and meta-analysis
Gabriele Torino, Martina Rignanese, Eleonora Salmè, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 19, 2023
Orbitofrontal sulcal patterns in catatonia
Mylène Moyal, Alexandre Haroche, David Attali, et al.
Frontiers in Psychiatry
|
August 1, 2020
Employment, Studies and Feelings: Two to Nine Years After a Personalized Program of Cognitive Remediation in Psychiatric Patients
Isabelle Amado, Mona Moualla, Julia Jouve, et al.
Schizophrenia Research. Cognition
|
December 12, 2018
From "under" to "over" social cognition in schizophrenia: Is there distinct profiles of impairments according to negative and positive symptoms?
Elodie Peyroux, Zelda Prost, Charlotte Danset-Alexandre, et al.
Frontiers in Pharmacology
|
November 17, 2022
Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine
Rodolphe H Lebeau, Indira Mendez-David, Laura Kucynski-Noyau, et al.
International Journal of Antimicrobial Agents
|
January 2, 2021
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Marion Plaze, David Attali, Matthieu Prot, et al.
Psychiatry Research
|
March 3, 2026
Personalized approach to cognitive remediation for people with schizophrenia and autism
Lindsay Brenugat, Mauricette Mendy, Alienor Maitre, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Frontiers in Psychiatry
|
May 16, 2022
Efficacy of Transcranial Direct-Current Stimulation in Catatonia: A Review and Case Series
Alexandre Haroche, Nolwenn Giraud, Fabien Vinckier, et al.
Science Advances
|
December 15, 2021
Ultrasound modulation of macaque prefrontal cortex selectively alters credit assignment-related activity and behavior
Davide Folloni, Elsa Fouragnan, Marco K Wittmann, et al.
Physics in Medicine and Biology
|
May 22, 2024
Ultra-short time-echo based ray tracing for transcranial focused ultrasound aberration correction in human calvaria
Thomas J Manuel, Thomas Bancel, Thomas Tiennot, et al.
Psychiatry Research
|
January 31, 2025
Physical pain and suicide-related outcomes across the lifespan: systematic review and meta-analysis
Gabriele Torino, Martina Rignanese, Eleonora Salmè, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
October 19, 2023
Orbitofrontal sulcal patterns in catatonia
Mylène Moyal, Alexandre Haroche, David Attali, et al.
Frontiers in Psychiatry
|
August 1, 2020
Employment, Studies and Feelings: Two to Nine Years After a Personalized Program of Cognitive Remediation in Psychiatric Patients
Isabelle Amado, Mona Moualla, Julia Jouve, et al.
Schizophrenia Research. Cognition
|
December 12, 2018
From "under" to "over" social cognition in schizophrenia: Is there distinct profiles of impairments according to negative and positive symptoms?
Elodie Peyroux, Zelda Prost, Charlotte Danset-Alexandre, et al.
Frontiers in Pharmacology
|
November 17, 2022
Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine
Rodolphe H Lebeau, Indira Mendez-David, Laura Kucynski-Noyau, et al.
International Journal of Antimicrobial Agents
|
January 2, 2021
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Marion Plaze, David Attali, Matthieu Prot, et al.
Psychiatry Research
|
March 3, 2026
Personalized approach to cognitive remediation for people with schizophrenia and autism
Lindsay Brenugat, Mauricette Mendy, Alienor Maitre, et al.
Page
of 3